Outcome of tricuspid valve surgery in the presence of permanent pacemaker

Nishant Saran, Sameh M. Said, Hartzell V Schaff, Simon Maltais, John M. Stulak, Kevin L. Greason, Richard C. Daly, Alberto Pochettino, Katherine S. King, Joseph A. Dearani

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives: Given the paucity of available literature, we sought to evaluate the mechanisms of tricuspid regurgitation and the outcomes of tricuspid valve surgery in the presence of permanent pacemakers. Methods: We retrospectively reviewed the records of 622 adult patients who underwent tricuspid valve surgery in the presence of permanent pacemakers between January 1993 and December 2013. Those with prosthetic tricuspid valve or tricuspid valve endocarditis and those undergoing concomitant heart transplant were excluded (n = 23). Patients were divided into 2 etiologic groups: pacemaker-associated tricuspid regurgitation (n = 349, 58%) and pacemaker-induced tricuspid regurgitation (n = 249, 42%). One patient was not categorized, because permanent pacemaker involvement was unknown. Results: Mean age was 69.5 ± 12.0 years; 312 patients (52%) were female. In pacemaker-associated tricuspid regurgitation, the most common cause was functional (n = 304, 87%). The most common mechanism leading to pacemaker-induced tricuspid regurgitation was restricted leaflet mobility (n = 101, 41%), followed by adherent leaflet to the leads (n = 93, 37%), leaflet perforation (n = 30, 12%), scarring of leaflets (n = 19, 8%), and chordal entrapment (n = 18, 7%). The most common leaflet involved was septal leaflet (n = 182, 73%). Tricuspid valve repair (n = 215, 62%) was higher in the pacemaker-associated tricuspid regurgitation group. In multivariable analysis, pacemaker-induced tricuspid regurgitation was found to be protective with improved survival (hazard ratio [HR], 0.79; 95% confidence interval [CI], 0.68-0.98). Other independent risk factors of mortality included tricuspid valve replacement (HR, 1.50; 95% CI, 1.20-1.87), nonelective surgery (HR, 1.66; 95% CI, 1.33-2.08), diabetes (HR, 1.37; 95% CI, 1.09-1.73), severe tricuspid regurgitation (HR, 1.42; 95% CI, 1.04-1.95), and older age when there was a concomitant aortic valve surgery (HR, 1.44; 95% CI, 1.15-1.79). Conclusions: Several mechanisms lead to pacemaker-induced tricuspid regurgitation. Pacemaker-induced tricuspid regurgitation when compared with pacemaker-associated tricuspid regurgitation carries a better prognosis with improved survival.

Original languageEnglish (US)
Pages (from-to)1498-1508.e3
JournalJournal of Thoracic and Cardiovascular Surgery
Volume155
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Tricuspid Valve Insufficiency
Tricuspid Valve
Confidence Intervals
Endocarditis
Aortic Valve
Cicatrix

Keywords

  • permanent pacemaker
  • tricuspid valve
  • tricuspid valve regurgitation

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Outcome of tricuspid valve surgery in the presence of permanent pacemaker. / Saran, Nishant; Said, Sameh M.; Schaff, Hartzell V; Maltais, Simon; Stulak, John M.; Greason, Kevin L.; Daly, Richard C.; Pochettino, Alberto; King, Katherine S.; Dearani, Joseph A.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 155, No. 4, 01.04.2018, p. 1498-1508.e3.

Research output: Contribution to journalArticle

Saran, N, Said, SM, Schaff, HV, Maltais, S, Stulak, JM, Greason, KL, Daly, RC, Pochettino, A, King, KS & Dearani, JA 2018, 'Outcome of tricuspid valve surgery in the presence of permanent pacemaker', Journal of Thoracic and Cardiovascular Surgery, vol. 155, no. 4, pp. 1498-1508.e3. https://doi.org/10.1016/j.jtcvs.2017.11.093
Saran, Nishant ; Said, Sameh M. ; Schaff, Hartzell V ; Maltais, Simon ; Stulak, John M. ; Greason, Kevin L. ; Daly, Richard C. ; Pochettino, Alberto ; King, Katherine S. ; Dearani, Joseph A. / Outcome of tricuspid valve surgery in the presence of permanent pacemaker. In: Journal of Thoracic and Cardiovascular Surgery. 2018 ; Vol. 155, No. 4. pp. 1498-1508.e3.
@article{5baa60fe947146d288df15a5fe767e8b,
title = "Outcome of tricuspid valve surgery in the presence of permanent pacemaker",
abstract = "Objectives: Given the paucity of available literature, we sought to evaluate the mechanisms of tricuspid regurgitation and the outcomes of tricuspid valve surgery in the presence of permanent pacemakers. Methods: We retrospectively reviewed the records of 622 adult patients who underwent tricuspid valve surgery in the presence of permanent pacemakers between January 1993 and December 2013. Those with prosthetic tricuspid valve or tricuspid valve endocarditis and those undergoing concomitant heart transplant were excluded (n = 23). Patients were divided into 2 etiologic groups: pacemaker-associated tricuspid regurgitation (n = 349, 58{\%}) and pacemaker-induced tricuspid regurgitation (n = 249, 42{\%}). One patient was not categorized, because permanent pacemaker involvement was unknown. Results: Mean age was 69.5 ± 12.0 years; 312 patients (52{\%}) were female. In pacemaker-associated tricuspid regurgitation, the most common cause was functional (n = 304, 87{\%}). The most common mechanism leading to pacemaker-induced tricuspid regurgitation was restricted leaflet mobility (n = 101, 41{\%}), followed by adherent leaflet to the leads (n = 93, 37{\%}), leaflet perforation (n = 30, 12{\%}), scarring of leaflets (n = 19, 8{\%}), and chordal entrapment (n = 18, 7{\%}). The most common leaflet involved was septal leaflet (n = 182, 73{\%}). Tricuspid valve repair (n = 215, 62{\%}) was higher in the pacemaker-associated tricuspid regurgitation group. In multivariable analysis, pacemaker-induced tricuspid regurgitation was found to be protective with improved survival (hazard ratio [HR], 0.79; 95{\%} confidence interval [CI], 0.68-0.98). Other independent risk factors of mortality included tricuspid valve replacement (HR, 1.50; 95{\%} CI, 1.20-1.87), nonelective surgery (HR, 1.66; 95{\%} CI, 1.33-2.08), diabetes (HR, 1.37; 95{\%} CI, 1.09-1.73), severe tricuspid regurgitation (HR, 1.42; 95{\%} CI, 1.04-1.95), and older age when there was a concomitant aortic valve surgery (HR, 1.44; 95{\%} CI, 1.15-1.79). Conclusions: Several mechanisms lead to pacemaker-induced tricuspid regurgitation. Pacemaker-induced tricuspid regurgitation when compared with pacemaker-associated tricuspid regurgitation carries a better prognosis with improved survival.",
keywords = "permanent pacemaker, tricuspid valve, tricuspid valve regurgitation",
author = "Nishant Saran and Said, {Sameh M.} and Schaff, {Hartzell V} and Simon Maltais and Stulak, {John M.} and Greason, {Kevin L.} and Daly, {Richard C.} and Alberto Pochettino and King, {Katherine S.} and Dearani, {Joseph A.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.jtcvs.2017.11.093",
language = "English (US)",
volume = "155",
pages = "1498--1508.e3",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Outcome of tricuspid valve surgery in the presence of permanent pacemaker

AU - Saran, Nishant

AU - Said, Sameh M.

AU - Schaff, Hartzell V

AU - Maltais, Simon

AU - Stulak, John M.

AU - Greason, Kevin L.

AU - Daly, Richard C.

AU - Pochettino, Alberto

AU - King, Katherine S.

AU - Dearani, Joseph A.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Objectives: Given the paucity of available literature, we sought to evaluate the mechanisms of tricuspid regurgitation and the outcomes of tricuspid valve surgery in the presence of permanent pacemakers. Methods: We retrospectively reviewed the records of 622 adult patients who underwent tricuspid valve surgery in the presence of permanent pacemakers between January 1993 and December 2013. Those with prosthetic tricuspid valve or tricuspid valve endocarditis and those undergoing concomitant heart transplant were excluded (n = 23). Patients were divided into 2 etiologic groups: pacemaker-associated tricuspid regurgitation (n = 349, 58%) and pacemaker-induced tricuspid regurgitation (n = 249, 42%). One patient was not categorized, because permanent pacemaker involvement was unknown. Results: Mean age was 69.5 ± 12.0 years; 312 patients (52%) were female. In pacemaker-associated tricuspid regurgitation, the most common cause was functional (n = 304, 87%). The most common mechanism leading to pacemaker-induced tricuspid regurgitation was restricted leaflet mobility (n = 101, 41%), followed by adherent leaflet to the leads (n = 93, 37%), leaflet perforation (n = 30, 12%), scarring of leaflets (n = 19, 8%), and chordal entrapment (n = 18, 7%). The most common leaflet involved was septal leaflet (n = 182, 73%). Tricuspid valve repair (n = 215, 62%) was higher in the pacemaker-associated tricuspid regurgitation group. In multivariable analysis, pacemaker-induced tricuspid regurgitation was found to be protective with improved survival (hazard ratio [HR], 0.79; 95% confidence interval [CI], 0.68-0.98). Other independent risk factors of mortality included tricuspid valve replacement (HR, 1.50; 95% CI, 1.20-1.87), nonelective surgery (HR, 1.66; 95% CI, 1.33-2.08), diabetes (HR, 1.37; 95% CI, 1.09-1.73), severe tricuspid regurgitation (HR, 1.42; 95% CI, 1.04-1.95), and older age when there was a concomitant aortic valve surgery (HR, 1.44; 95% CI, 1.15-1.79). Conclusions: Several mechanisms lead to pacemaker-induced tricuspid regurgitation. Pacemaker-induced tricuspid regurgitation when compared with pacemaker-associated tricuspid regurgitation carries a better prognosis with improved survival.

AB - Objectives: Given the paucity of available literature, we sought to evaluate the mechanisms of tricuspid regurgitation and the outcomes of tricuspid valve surgery in the presence of permanent pacemakers. Methods: We retrospectively reviewed the records of 622 adult patients who underwent tricuspid valve surgery in the presence of permanent pacemakers between January 1993 and December 2013. Those with prosthetic tricuspid valve or tricuspid valve endocarditis and those undergoing concomitant heart transplant were excluded (n = 23). Patients were divided into 2 etiologic groups: pacemaker-associated tricuspid regurgitation (n = 349, 58%) and pacemaker-induced tricuspid regurgitation (n = 249, 42%). One patient was not categorized, because permanent pacemaker involvement was unknown. Results: Mean age was 69.5 ± 12.0 years; 312 patients (52%) were female. In pacemaker-associated tricuspid regurgitation, the most common cause was functional (n = 304, 87%). The most common mechanism leading to pacemaker-induced tricuspid regurgitation was restricted leaflet mobility (n = 101, 41%), followed by adherent leaflet to the leads (n = 93, 37%), leaflet perforation (n = 30, 12%), scarring of leaflets (n = 19, 8%), and chordal entrapment (n = 18, 7%). The most common leaflet involved was septal leaflet (n = 182, 73%). Tricuspid valve repair (n = 215, 62%) was higher in the pacemaker-associated tricuspid regurgitation group. In multivariable analysis, pacemaker-induced tricuspid regurgitation was found to be protective with improved survival (hazard ratio [HR], 0.79; 95% confidence interval [CI], 0.68-0.98). Other independent risk factors of mortality included tricuspid valve replacement (HR, 1.50; 95% CI, 1.20-1.87), nonelective surgery (HR, 1.66; 95% CI, 1.33-2.08), diabetes (HR, 1.37; 95% CI, 1.09-1.73), severe tricuspid regurgitation (HR, 1.42; 95% CI, 1.04-1.95), and older age when there was a concomitant aortic valve surgery (HR, 1.44; 95% CI, 1.15-1.79). Conclusions: Several mechanisms lead to pacemaker-induced tricuspid regurgitation. Pacemaker-induced tricuspid regurgitation when compared with pacemaker-associated tricuspid regurgitation carries a better prognosis with improved survival.

KW - permanent pacemaker

KW - tricuspid valve

KW - tricuspid valve regurgitation

UR - http://www.scopus.com/inward/record.url?scp=85043432896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043432896&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2017.11.093

DO - 10.1016/j.jtcvs.2017.11.093

M3 - Article

VL - 155

SP - 1498-1508.e3

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 4

ER -